Exploiting the Body's Immune System to Treat a Broad Range of Diseases

Read more

ARMO in the News

01/25/18 — ARMO BioSciences Announces Pricing of Initial Public Offering  Read more

12/08/17 — ARMO BioSciences Presents Efficacy Data from its Phase 1b Trial in Patients with Metastatic Renal Cell Carcinoma at ESMO Immuno-Oncology Congress 2017  Read more

11/28/17 — ARMO BioSciences Appoints Herb Cross as Chief Financial Officer  Read more